Novavax is a biotechnology company committed to helping to address serious infectious diseases globally through the discovery, development, and delivery of innovative vaccines to patients around the world.

Resources prepared for you to answer your questions

Global authorization site of Novavax COVID-19 Vaccine (recombinant, adjuvanted)

Product summary for healthcare professionals, patient information, expiry date checker, FAQs, and more

Global medical information site

Ask medical questions, report adverse events, and report product quality complaints


Source in-depth information about our research areas

Matrix-M adjuvant production process

Our vaccine uses saponins, from the Quillaja saponaria tree, to help generate a robust immune response.

Producing a Novavax vaccine

Learn more about the 6 step process used to manufacture our vaccine.

Investigator-Initiated Studies (IIS)

The Novavax IIS program supports clinical and non-clinical research that addresses important unmet scientific or medical needs aligned with Novavax's areas of interest. Support for an approved IIS may include funding, Novavax product, or both.

Become a clinical trial site with Novavax

If you are interested in participating as a clinical trial site with Novavax, please complete the site questionnaire.

Science & technology

Recombinant nanoparticle vaccine technology

Science & technology

Matrix-M™ adjuvant technology

Science & technology

Our pipeline—creating tomorrow's vaccine today

Want to learn more about our vaccines?

green graphic image